MRLN stock fell 37.81% over the past month as geopolitical tensions weighed on broader market performance in Q1 2026.
Merlin Labs (NASDAQ:MRLN) closed at $7.09 on May 22, 2026, marking a 37.81% decline over the past month. The aerospace and defense firm’s shares have lost 30.29% over the past 52 weeks, with a market capitalization of $684.36 million.
The drop aligns with broader market trends, as the S&P 500 fell 4.3% in Q1 2026 due to geopolitical tensions linked to unpredictable foreign policy shifts. Crossroads Capital LLC noted stable market trends from 2025 were disrupted, though Q1 fundamentals remained consistent with expectations.
Crossroads Capital, which holds MRLN in its portfolio, reported a 4.2% net gain for its fund in Q1 2026, despite the volatility. The firm maintained exposure to special situations, signaling confidence in long-term positioning.